Reaktion #477898

ord-277e0560c39b4dcc9d18ab741e2d1fa4

Reaktionsgleichung

Cc1cnc(NC(=O)N2CC[C@@H](F)C2)s1
(3R)-3-fluoro-N-(5-methyl-1,3-thiazol-2-yl)pyrrolidine-1-carboxamide
Clc1cc2cccnc2c2ncccc12
5-chloro-1,10-phenanthroline
Brc1cccc(Br)c1
1,3-Dibromobenzene
O.[NH4+].[OH-]
ammonium hydroxide water
O=C([O-])[O-].[Cs+].[Cs+]
cesium carbonate
Cc1cn(-c2cccc(Br)c2)/c(=N/C(=O)N2CC[C@@H](F)C2)s1
title compound
Cc1cn(-c2cccc(Br)c2)/c(=N/C(=O)N2CC[C@@H](F)C2)s1
(3R)-N-[(2Z)-3-(3-bromophenyl)-5-methyl-1,3-thiazol-2(3H)-ylidene]-3-fluoropyrrolidine-1-carboxamide

Reaktionsbedingungen

Temperatur
120°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    workup.ADDITIONIn a 4 mL vial charged with a stir bar
  2. 2
    SonstigeA loose cap with septum
  3. 3
    SonstigeThe mixture was purged with nitrogen gas a couple of times
  4. 4
    workup.ADDITIONwas added to the mixture
  5. 5
    SonstigeThe vial was capped
  6. 6
    Sonstigeplaced on a heater/stirrer
  7. 7
    FiltrationThe reaction was filtered
  8. 8
    Einengenconcentrated to dryness
  9. 9
    SonstigeThe residue was purified by reverse phase HPLC (C8, gradient 10-100% acetonitrile/water/0.1% trifluoroacetic acid)

Vorschrift

In a 4 mL vial charged with a stir bar, (3R)-3-fluoro-N-(5-methyl-1,3-thiazol-2-yl)pyrrolidine-1-carboxamide (40 mg, 0.17 mmol, Example 34A) was added, followed by copper(I) trifluoromethanesulfonate benzene complex (17 mg, 0.03 mmol), 5-chloro-1,10-phenanthroline (15 mg, 0.07 mmol) and cesium carbonate (61 mg, 0.19 mmol). A loose cap with septum was placed on the vial and then the vial was placed under vacuum in a vacuum oven for 30 minutes. The mixture was purged with nitrogen gas a couple of times. 1,3-Dibromobenzene (47 mg, 0.2 mmol) dissolved in 1-methyl-2-pyrrolidinone (1.0 mL) was added to the mixture. The vial was capped and placed on a heater/stirrer and heated to 120° C. overnight. Then 1 mL of a solution of concentrated ammonium hydroxide/water (1:2) was added. The reaction was filtered and concentrated to dryness. The residue was purified by reverse phase HPLC (C8, gradient 10-100% acetonitrile/water/0.1% trifluoroacetic acid) to provide the title compound.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08383657B2uspto-grants-2013_02